Previous intravenous chemotherapy does not alter response rate or survival time of patients with hepatic metastases from colorectal cancer treated by hepatic artery chemotherapy

Australian and New Zealand Journal of Surgery

Volumn 67, Issue 11, 1997, Pages 796-797

  Morris, David L ^a,b   Zhao, Jing ^a   Clingan, Philip R ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

Chemotherapy; Colorectal cancer; Hepatic artery chemotherapy

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL;

ARTICLE; CANCER CHEMOTHERAPY; COLORECTAL CANCER; HEPATIC ARTERY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER METASTASIS; MAJOR CLINICAL STUDY; SURVIVAL TIME;

EID: 0030668102     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.1997.tb04583.x     Document Type: Article

References (7)

1. McCall J, Jorgensen J, Morris DL. Hepatic artery chemotherapy for colorectal liver metastases. Aust. N.Z. J. Surg. 1995; 65: 383-9.
2. Rougier P, Laplanche A, Huguier M et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long term results of a prospective randomised trial. J. Clin. Onc. 1992; 10: 1112-18.
3. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994; 344: 1255-60.
4. Morris DL, Horton MDA'C, Dilley AV, Warlter A, Clingan PR. The treatment of hepatic metastases by cryotherapy and regional cytotoxic perfusion. Gut 1993; 34: 1156-7.
5. Quentmeier A, Schlag P, Hohenberger P, Schwarz V, Abel U. Assessment of serial carcinoembryonic antigen determinations to monitor the therapeutic progress and prognosis of metastatic liver disease treated by regional chemotherapy. J. Surg. Onc. 1989; 40: 112-18.
6. Preketes AP, King J, Caplehorn JRM, Clingan PR, Ross WB, Morris DL. CEA reduction after cryotherapy for liver metastases from colon cancer predicts survival. Aust. N.Z. J. Surg. 1994; 64: 612-14.
7. Kemeny N, Conti JA, Cohen A et al. Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J. Clin. Onc. 1994; 12: 2288-95.